FDA Adverse Event Injury Summary report: N

STAGE

MDR report key: 20024098 · Received August 22, 2024

Report

Report Number
3005990499-2024-71510
Event Type
Injury
Date Received
August 22, 2024
Date of Event
July 31, 2024
Report Date
August 20, 2024
Manufacturer
KEYSTONE DENTAL, INC.
Product Code
DZE
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
DENTIST
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

KEYSTONE DENTAL INC. PROVIDES LABELING WITH ALL IMPLANTS. FAILURE TO OSSEOINTEGRATE AND LOSS OF OSSEOINTEGRATION (IMPLANT MOBILITY) IS IDENTIFIED AS AN ADVERSE REACTION AND IDENTIFIED IN THE LIST OF WARNINGS IN ALL ENDOSSEOUS DENTAL IMPLANT LABELING. THE SPECIFIC CAUSE FOR A PARTICULAR COMPLAINT IS OFTEN NOT READILY IDENTIFIED AS THERE ARE VARIOUS FACTORS THAT CONTRIBUTE TO THE RISK OF IMPLANT FAILURE. THESE INCLUDE PATIENT FACTORS SUCH AS PRIOR ORAL INFECTION, POOR BONE QUALITY OR QUANTITY, SYSTEMIC CONDITIONS SUCH AS DIABETES AND UNCONTROLLED HYPERTENSION. TECHNIQUE FACTORS SUCH AS OVERHEATING OF THE IMPLANT SITE MAY CAUSE NECROSIS OF THE BONE, PREVENTING GROWTH (PELAYO ET AL., 2008; TURKYILMAZ & AL., 2008). PATIENT HABITS SUCH AS TOBACCO USE (HEITZ-MAYFIELD & HUYNH-BA, 2009), ALCOHOL OR DRUG ABUSE, POOR ORAL HYGIENE, AND BRUXISM (SALVI & BRAEGGER, 2009) MAY ALSO LED TO IMPLANT FAILURE. IN ADDITION, IMPROPER SURGICAL TECHNIQUE CAN LED TO IMPLANT FAILURE AND/OR LOSS OF SUPPORTING BONE (SALVI & BRAEGGER, 2009). ADDITIONAL HEALTH EFFECT CLINICAL CODE=2651, OSTEOPENIA.

Description of Event or Problem · 0

LOSS OF OSSEOINTEGRATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2378313 STAGE 3.3X12 RBM RDS STAGE1 IMP 2.8MM CL DZE KEYSTONE DENTAL, INC. RSR3312-3 004988

Patients

Seq Age Sex Outcome Treatment
1 67 YR Male Required Intervention